Published in Forensic Sci Int on May 31, 2009
Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int (2010) 0.89
The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr (2006) 1.22
DNA repair systems as targets of cadmium toxicity. Toxicol Appl Pharmacol (2006) 1.21
MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol (2010) 1.12
Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundam Clin Pharmacol (2007) 1.03
Cyto-histological correlations in primary, recurrent and metastatic rhabdomyosarcoma: the institut Curie's experience. Diagn Cytopathol (2007) 1.02
Insights on augmenter of liver regeneration cloning and function. World J Gastroenterol (2006) 1.01
Primary hydatid disease of the gallbladder: a rare clinical entity. J Hepatobiliary Pancreat Surg (2004) 1.00
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis. Pharmacol Res (2009) 0.98
Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol (2012) 0.97
Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity. Dig Dis Sci (2008) 0.97
Zinc and the liver: an active interaction. Dig Dis Sci (2007) 0.95
Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein. NMR Biomed (2009) 0.94
MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention. J Pharm Sci (2008) 0.92
Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival. Med Sci Monit (2009) 0.92
1H NMR-based metabonomics approach in a rat model of acute liver injury and regeneration induced by CCl4 administration. Toxicology (2012) 0.91
Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med (2010) 0.91
Correlation of Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression with clinical risk factors in patients with advanced carotid atherosclerosis. Med Sci Monit (2011) 0.91
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury. Curr Mol Med (2008) 0.91
Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma? Dig Dis Sci (2008) 0.90
Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci (2008) 0.90
NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert Opin Ther Targets (2014) 0.89
Toll-like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation? Expert Opin Ther Targets (2009) 0.89
Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis. Expert Opin Investig Drugs (2007) 0.89
MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. Dig Dis Sci (2010) 0.89
Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.87
Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials? World J Gastroenterol (2013) 0.86
Current evidence on the anticancer potential of Chios mastic gum. Nutr Cancer (2011) 0.86
Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer. PPAR Res (2008) 0.85
The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches? Expert Opin Ther Targets (2008) 0.85
Current clinical status on the preventive effects of cranberry consumption against urinary tract infections. Nutr Res (2013) 0.85
Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions. Tumour Biol (2013) 0.85
Clinical significance of HuR expression in human malignancy. Med Oncol (2014) 0.84
Current evidence for histone deacetylase inhibitors in pancreatic cancer. World J Gastroenterol (2013) 0.84
Multi-targeted molecular therapeutic approach in aggressive neuroblastoma: the effect of Focal Adhesion Kinase-Src-Paxillin system. Expert Opin Ther Targets (2014) 0.84
Ghrelin, another factor affecting bone metabolism. Med Sci Monit (2010) 0.84
Evaluation of FAK and Src expression in human benign and malignant thyroid lesions. Pathol Oncol Res (2010) 0.83
Primary liver tumors: origin and target therapy. Expert Opin Ther Targets (2009) 0.83
Pregnane X receptor (PXR) at the crossroads of human metabolism and disease. Curr Drug Metab (2013) 0.83
Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: associations with clinicopathological variables and patient survival. Int J Biol Markers (2010) 0.83
The role of peroxisome proliferator-activated receptor-γ in breast cancer. Anticancer Agents Med Chem (2012) 0.83
Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival. Pathol Oncol Res (2012) 0.83
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study. BMC Gastroenterol (2007) 0.82
Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit (2011) 0.82
Toll-like receptor 4 immunohistochemical expression is enhanced in macrophages of symptomatic carotid atherosclerotic plaques. Cerebrovasc Dis (2010) 0.82
Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions. APMIS (2010) 0.82
Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients. Int J Biol Markers (2009) 0.82
Management of the airway without the use of neuromuscular blocking agents: the use of remifentanil. Fundam Clin Pharmacol (2011) 0.82
Quantitative structure-pharmacokinetic relationships for disposition parameters of cephalosporins. Eur J Pharm Sci (2003) 0.82
Proteasome inhibitors: possible novel therapeutic strategy for ischemia-reperfusion injury? Expert Opin Investig Drugs (2013) 0.82
Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach? Expert Opin Ther Targets (2009) 0.81
Circadian variation in expression of G1 phase cyclins D1 and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa. World J Gastroenterol (2006) 0.81
Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics. Pharm Res (2002) 0.81
Anatomical landmarks: dimensions of the mastoid air cell system in the Mediterranean population. Our experience from the anatomy of 298 temporal bones. Anat Sci Int (2007) 0.81
Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na(+),K (+))- and Mg (2+)-ATPase: comparison of the enzymes' response to in vitro treatment with ammonia. Metab Brain Dis (2008) 0.81
Effects of short-term exposure to manganese on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na,K)-ATPase and Mg-ATPase: modulation by L-cysteine. Basic Clin Pharmacol Toxicol (2008) 0.80
A consideration of PPAR-gamma ligands with respect to lipophilicity: current trends and perspectives. Expert Opin Investig Drugs (2007) 0.80
Fine-needle aspiration in desmoplastic small round cell tumor: a report of 10 new tumors in 8 patients with clinicopathological and molecular correlations with review of the literature. Cancer Cytopathol (2014) 0.80
Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit (2011) 0.80
Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions. Med Sci Monit (2012) 0.80
Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. Tumour Biol (2014) 0.80
An epitome of DNA repair related genes and mechanisms in thyroid carcinoma. Cancer Lett (2009) 0.80
Farnesoid X Receptor (FXR) from normal to malignant state. Histol Histopathol (2012) 0.80
Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach. J Appl Toxicol (2009) 0.79
Retention of structurally diverse drugs in human serum albumin chromatography and its potential to simulate plasma protein binding. J Chromatogr A (2010) 0.79
Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease? Expert Opin Ther Targets (2008) 0.79
Assessing drug transport across the human placental barrier: from in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques. Curr Pharm Biotechnol (2011) 0.79
Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples. J BUON (2015) 0.78
In silico prediction of human serum albumin binding for drug leads. Expert Opin Drug Discov (2013) 0.78
Octanol/water partitioning simulation by reversed-phase high performance liquid chromatography for structurally diverse acidic drugs: Effect of n-octanol as mobile phase additive. J Chromatogr A (2007) 0.78
Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions. Pathol Oncol Res (2016) 0.78
PPAR-gamma signaling pathway in placental development and function: a potential therapeutic target in the treatment of gestational diseases. Expert Opin Ther Targets (2008) 0.78
Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction. Clin Chem Lab Med (2008) 0.78
Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med (2004) 0.78
Retention of substituted coumarins using immobilized artificial membrane (IAM) chromatography: a comparative study with n-octanol partitioning and reversed-phase HPLC and TLC. J Pharm Biomed Anal (2005) 0.78
Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning. J Chromatogr A (2008) 0.78
The role of serum total ghrelin level elevation in colon cancer patients. J BUON (2014) 0.78
Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning. J Chromatogr A (2006) 0.78
Acute liver acetaminophen toxicity in rabbits and the use of antidotes: a metabonomic approach in serum. J Appl Toxicol (2009) 0.78
Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier. Expert Opin Drug Metab Toxicol (2012) 0.77
Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury? Expert Opin Ther Targets (2010) 0.77
Histone deacetylase inhibitors in oral squamous cell carcinoma treatment. Expert Opin Investig Drugs (2014) 0.77
Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility. Expert Opin Drug Metab Toxicol (2015) 0.77
Metallothionein expression in the high-risk carotid atherosclerotic plaque. Curr Med Res Opin (2007) 0.77
Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits. Eur J Pharm Sci (2006) 0.77
Histone deacetylase inhibitors as potential therapeutic agents for the treatment of malignant mesothelioma. Anticancer Agents Med Chem (2013) 0.77
Physicochemical profile of nimesulide. Exploring the interplay of lipophilicity, solubility and ionization. J Pharm Biomed Anal (2007) 0.77
Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins. Vascular (2011) 0.77
Pregnane X receptor polymorphisms associated with human diseases. Expert Opin Ther Targets (2013) 0.77
Quantitative structure-activity relationships for PPAR-gamma binding and gene transactivation of tyrosine-based agonists using multivariate statistics. Chem Biol Drug Des (2008) 0.77
Structural basis for the design of PPAR-gamma ligands: a survey on quantitative structure- activity relationships. Mini Rev Med Chem (2009) 0.76